mhurhangee/patent-ind-claim-en huggingface dataset:
A coated paperboard, comprising: a paperboard substrate; a coating in contact with the paperboard substrate, the coating comprising binder and pigment, the pigment comprising at least one of a clay and calcium carbonate, the coating containing substantially no fluorochemical or wax; wherein the binder comprises synthetic and natural binders; wherein the binder to pigment ratio in the coating is between 25 to 40 parts binder per 100 parts pigment, by weight; wherein the coated paperboard has a caliper of at least 254μm (0.010"); wherein the coated paperboard provides barrier properties to at least one of oil, grease, and moisture; and wherein the coated paperboard is compostable according to the ASTM D6868-11 standard for compostability. a paperboard substrate; a coating in contact with the paperboard substrate, the coating comprising binder and pigment, the pigment comprising at least one of a clay and calcium carbonate, the coating containing substantially no fluorochemical or wax; wherein the binder comprises synthetic and natural binders; wherein the binder to pigment ratio in the coating is between 25 to 40 parts binder per 100 parts pigment, by weight; wherein the coated paperboard has a caliper of at least 254μm (0.010"); wherein the coated paperboard provides barrier properties to at least one of oil, grease, and moisture; and wherein the coated paperboard is compostable according to the ASTM D6868-11 standard for compostability.
A device for generating and delivering NO to a treatment site, comprising: a main unit ; an applicator ; a connector hose ; and a mobile stand ; wherein the main unit provides power and a gas to the applicator via the connector hose , the applicator including a plasma generator for generating Nitric Oxide (NO) in a plasma state, wherein the applicator comprises: a pistol grip handle ; a trigger for actuating the plasma generator; a hose connection for coupling to the connector hose ; and a cowl portion for spacing a tip of the plasma generator at a predetermined distance from a treatment site. a main unit ; an applicator ; a connector hose ; and a mobile stand ; a pistol grip handle ; a trigger for actuating the plasma generator; a hose connection for coupling to the connector hose ; and a cowl portion for spacing a tip of the plasma generator at a predetermined distance from a treatment site.
A replaceable atomizing unit , comprising: a liquid conducting body ; a heating element in contact with the liquid conducting body ; a holder configured for supporting the liquid conducting body , the holder comprising an open end ; and a press fit element coupled with the open end , the press fit element and the holder cooperatively defining an atomizing chamber , the heating element being received in the atomizing chamber , wherein the open end defines a gap for accommodating the liquid conducting body , at least one part of the liquid conducting body extends along the gap outside of the atomizing chamber , characterized in that the atomizing unit further comprises a resilient component nesting the open end , and in that the resilient component is tightly pressed against the liquid conducting body by the press fit element . a liquid conducting body ; a heating element in contact with the liquid conducting body ; a holder configured for supporting the liquid conducting body , the holder comprising an open end ; and a press fit element coupled with the open end , the press fit element and the holder cooperatively defining an atomizing chamber , the heating element being received in the atomizing chamber , wherein the open end defines a gap for accommodating the liquid conducting body , at least one part of the liquid conducting body extends along the gap outside of the atomizing chamber , characterized in that the atomizing unit further comprises a resilient component nesting the open end , and in that the resilient component is tightly pressed against the liquid conducting body by the press fit element .
A rotor for a blood circulating pump for the circulation of blood, the rotor comprising a magnetic, biocompatible body having an upstream end , a downstream end and an axis (R) extending between the ends on which the rotor circumferentially rotates, the body including a plurality of vanes defining a plurality of channels therebetween, the rotor being constructed and arranged to impel blood downstream upon rotation of the rotor about the axis in a forward circumferential direction (FC), the vanes defining chamfer surfaces , the chamfer surfaces being in the form of portions of a conical surface of revolution about the axis having increasing diameter in the downstream direction (D), wherein the chamfer surfaces include a chamfer angle such that the chamfer surfaces are positioned at an angle relative to the axis, characterized in that : the chamfer angle is in the range of 20 degrees to less than 45 degrees, the vanes have hydrodynamic thrust bearing surfaces provided as portions of the chamfer surfaces and recessed relative to surrounding portions of the chamfer surfaces such that each thrust bearing surface defines a pocket in the chamfer surfaces, wherein each said pocket in the chamfer surface has a progressively increasing depth in the circumferentially forward direction, and each such thrust bearing surface is constructed and arranged to apply a hydrodynamic force (V) to the rotor with a component of the force in a downstream direction along the axis upon rotation of the rotor in the forward circumferential direction. the chamfer angle is in the range of 20 degrees to less than 45 degrees, the vanes have hydrodynamic thrust bearing surfaces provided as portions of the chamfer surfaces and recessed relative to surrounding portions of the chamfer surfaces such that each thrust bearing surface defines a pocket in the chamfer surfaces, wherein each said pocket in the chamfer surface has a progressively increasing depth in the circumferentially forward direction, and each such thrust bearing surface is constructed and arranged to apply a hydrodynamic force (V) to the rotor with a component of the force in a downstream direction along the axis upon rotation of the rotor in the forward circumferential direction.
Sorting device for tablets for separating out multiple tablets , having a plurality of stations comprising a feed station , a sorting station and an ejection station , and having a tablet transporter which moves to the individual stations in a direction of rotation , wherein the tablet transporter comprises at least one row of tablet receivers for single tablets and at least one doublet receiver , positioned laterally next to the tablet receivers , for multiple tablets which have been separated out, wherein an individual tablet receiver is laterally separated from the doublet receiver by means of a side wall , and wherein there is provided in the sorting station at least one sorting tine which can be moved to and fro over a travel range in a lateral direction extending transversely to the direction of rotation in such a manner that the sorting tine thereby passes over the region of a tablet receiver , the adjacent doublet receiver and the side wall located between them.
An apparatus provided in a communications device, said apparatus comprising means for: determining (T1) that at least one of a plurality of logical channels configured for packet duplication is to be deactivated, wherein a plurality of logical channels remains active for the packet duplication after deactivation of the at least one of the plurality of logical channels configured for packet duplication; and determining (T2) an allocation of one or more cells associated with the at least one deactivated logical channel to one or more active logical channels associated with a same cell group as the at least one deactivated logical channel, wherein the packet duplication comprises a dual connectivity -based packet duplication and a carrier aggregation -based packet duplication in each of at least two cell groups of the dual connectivity -based packet duplication. determining (T1) that at least one of a plurality of logical channels configured for packet duplication is to be deactivated, wherein a plurality of logical channels remains active for the packet duplication after deactivation of the at least one of the plurality of logical channels configured for packet duplication; and determining (T2) an allocation of one or more cells associated with the at least one deactivated logical channel to one or more active logical channels associated with a same cell group as the at least one deactivated logical channel, wherein the packet duplication comprises a dual connectivity -based packet duplication and a carrier aggregation -based packet duplication in each of at least two cell groups of the dual connectivity -based packet duplication.
A control system configured to exhaust gas from a building, the control system comprising: a common duct configured to carry the exhaust gas; a plenum in fluid communication with the common duct and configured to receive the exhaust gas from the common duct; an exhaust fan in fluid communication with the plenum, the exhaust fan being configured to draw gas through the plenum so as to discharge the gas through an outlet, and including an adjustable speed fan drive that operates the exhaust fan at variable speeds; and a first static pressure probe disposed in the common duct and a second static pressure probe disposed in the plenum , the first and second static pressure probes operable to measure a static pressure of the exhaust gas, wherein the control system receives inputs from the static pressure probes and controls the speed of the exhaust fan so as to maintain a discharge velocity of gas at the outlet at or above a minimum exhaust gas flow rate. a common duct configured to carry the exhaust gas; a plenum in fluid communication with the common duct and configured to receive the exhaust gas from the common duct; an exhaust fan in fluid communication with the plenum, the exhaust fan being configured to draw gas through the plenum so as to discharge the gas through an outlet, and including an adjustable speed fan drive that operates the exhaust fan at variable speeds; and a first static pressure probe disposed in the common duct and a second static pressure probe disposed in the plenum , the first and second static pressure probes operable to measure a static pressure of the exhaust gas, wherein the control system receives inputs from the static pressure probes and controls the speed of the exhaust fan so as to maintain a discharge velocity of gas at the outlet at or above a minimum exhaust gas flow rate.
A hydromassage tub (100*) provided with jet delivery elements including a device (200*) for the production of an air/water mixture jet, said device (200*) being fixed to a wall (WL*) of said tub (100*) itself; said tub (100*) being provided with an opening formed on the wall (WL*) to which said device (200*) is associated, the device being provided with a diffuser element (27*) ending with an outlet mouth (27D*) of an air/water mixture jet outlet towards the inside the tub (100*) itself; characterized in that said opening is a slot (300*), wherein said outlet mouth (27D*) is set upon said slot (300*) so that the outline of said outlet mouth (27D*) itself matches the outline of said slot (300*); and said outlet mouth (27D*) of said diffuser element (27*) resting directly on said slot (300*) created directly on said wall (WL*) of said tub (100*); and in that all jet delivery elements and all elements attaching the device (200*) to the wall (WL*) are arranged outside an internal surface (φ*) of the wall (WL*) itself.
An information transmission method, comprising: receiving (S210), by a positioning center, a location service request message from a core network device, wherein the location service request message comprises coverage indication information, wherein the coverage indication information indicates that a user equipment, UE, is at a coverage enhancement level; determining, by the positioning center according to the coverage indication information, positioning measurement configuration information; and sending (S220), by the positioning center, the positioning measurement configuration information to the UE, wherein the positioning measurement configuration information configures the UE to perform positioning measurement. receiving (S210), by a positioning center, a location service request message from a core network device, wherein the location service request message comprises coverage indication information, wherein the coverage indication information indicates that a user equipment, UE, is at a coverage enhancement level; determining, by the positioning center according to the coverage indication information, positioning measurement configuration information; and sending (S220), by the positioning center, the positioning measurement configuration information to the UE, wherein the positioning measurement configuration information configures the UE to perform positioning measurement.
Pentafluorosulfanyl pyridine represented by formula (d): wherein a SFs group binds to either one of position-3 or position-4 of a pyridine ring, and R 2 binds to the other one of position-3 or position-4; and R 1 , R 2 , R 3 , and R 4 are independently a hydrogen atom, a halogen atom, an alkyl group having 1 to 18 carbon atoms, an aryl group having 6 to 30 carbon atoms, a nitro group, a cyano group, an alkanesulfonyl group having 1 to 18 carbon atoms, an arenesulfonyl group having 6 to 30 carbon atoms, an alkoxy group having 1 to 18 carbon atoms, an aryloxy group having 6 to 30 carbon atoms, an acyloxy group having 1 to 18 carbon atoms, an alkanesulfonyloxy group having 1 to 18 carbon atoms, an arenesulfonyloxy group having 6 to 30 carbon atoms, an alkoxycarbonyl group having 2 to 18 carbon atoms, an aryloxycarbonyl group having 7 to 30 carbon atoms, a benzylamino group, an amino group, an azide group, an aralkyloxy group having 7 to 30 carbon atoms, an aralkylsulfide group having 7 to 30 carbon atoms, or a SF 5 group); wherein at least one of the R 1 and R 4 is a fluorine atom. wherein a SFs group binds to either one of position-3 or position-4 of a pyridine ring, and R 2 binds to the other one of position-3 or position-4; and R 1 , R 2 , R 3 , and R 4 are independently a hydrogen atom, a halogen atom, an alkyl group having 1 to 18 carbon atoms, an aryl group having 6 to 30 carbon atoms, a nitro group, a cyano group, an alkanesulfonyl group having 1 to 18 carbon atoms, an arenesulfonyl group having 6 to 30 carbon atoms, an alkoxy group having 1 to 18 carbon atoms, an aryloxy group having 6 to 30 carbon atoms, an acyloxy group having 1 to 18 carbon atoms, an alkanesulfonyloxy group having 1 to 18 carbon atoms, an arenesulfonyloxy group having 6 to 30 carbon atoms, an alkoxycarbonyl group having 2 to 18 carbon atoms, an aryloxycarbonyl group having 7 to 30 carbon atoms, a benzylamino group, an amino group, an azide group, an aralkyloxy group having 7 to 30 carbon atoms, an aralkylsulfide group having 7 to 30 carbon atoms, or a SF 5 group); wherein at least one of the R 1 and R 4 is a fluorine atom.
A process for producing an agricultural admixture from a selected biological recyclable stream, the process comprising the steps of: (a) providing a biological recyclable stream using a collection system; (b) grinding the biological recyclable stream using a first grinder and optionally a second grinder to produce a ground biological slurry; (c) adding to said ground biological slurry one or more selected enzymes; (d) increasing the temperature of the first ground biological slurry from ambient temperature to at least one temperature between about 35 °C and about 60 °C (about 95 °F and about 140 °F) and incubating the first ground biological slurry under constant agitation and shear at two or more temperatures between about 35 °C and about 60 °C (about 95 °F and about 140 °F), thereby producing an incubated first biological slurry comprising first incubated biological particles and a first incubated biological hydrolysate; (e) pasteurizing the incubated ground biological slurry to kill pathogens; (f) separating the first incubated hydrolysate into a first incubated biological hydrolysate and first incubated biological particles using one or a plurality of size-based separation methods; and (g) reducing the fat content of the pasteurized first incubated hydrolysate to a range of between 1 to 4 wt% by tricanter centrifugation to form a centrifuged biological hydrolysate. (a) providing a biological recyclable stream using a collection system; (b) grinding the biological recyclable stream using a first grinder and optionally a second grinder to produce a ground biological slurry; (c) adding to said ground biological slurry one or more selected enzymes; (d) increasing the temperature of the first ground biological slurry from ambient temperature to at least one temperature between about 35 °C and about 60 °C (about 95 °F and about 140 °F) and incubating the first ground biological slurry under constant agitation and shear at two or more temperatures between about 35 °C and about 60 °C (about 95 °F and about 140 °F), thereby producing an incubated first biological slurry comprising first incubated biological particles and a first incubated biological hydrolysate; (e) pasteurizing the incubated ground biological slurry to kill pathogens; (f) separating the first incubated hydrolysate into a first incubated biological hydrolysate and first incubated biological particles using one or a plurality of size-based separation methods; and (g) reducing the fat content of the pasteurized first incubated hydrolysate to a range of between 1 to 4 wt% by tricanter centrifugation to form a centrifuged biological hydrolysate.
A method of providing information for diagnosing a risk of preterm birth, comprising detecting a Weissella microorganism in a sample of pregnant woman.
A pharmaceutical composition for use in treating cancer in combination with radiation wherein the composition comprises: a protein comprising; (a) a human TGFβRII, or fragment thereof capable of binding TGFβ; and (b) an antibody, or antigen-binding fragment thereof, binding human protein Programmed Death Ligand 1 (PD-L1) comprising (i) a heavy chain variable region including an HVR-H1, an HVR-H2, and an HVR-H3 having the amino acid sequences of SYIMM, SIYPSGGITFYADTVKG and IKLGTVTTVDY, respectively, and (ii) a light chain variable region including an HVR-L1, an HVR-L2, and an HVR-L3, having the amino acid sequences of TGTSSDVGGYNYVS, DVSNRPS, and SSYTSSSTRV, respectively, wherein the protein used in combination with radiation of a primary tumor inhibits the growth of a secondary tumor or metastasis distal to the primary tumor treated with radiation. a protein comprising; (a) a human TGFβRII, or fragment thereof capable of binding TGFβ; and (b) an antibody, or antigen-binding fragment thereof, binding human protein Programmed Death Ligand 1 (PD-L1) comprising (i) a heavy chain variable region including an HVR-H1, an HVR-H2, and an HVR-H3 having the amino acid sequences of SYIMM, SIYPSGGITFYADTVKG and IKLGTVTTVDY, respectively, and (ii) a light chain variable region including an HVR-L1, an HVR-L2, and an HVR-L3, having the amino acid sequences of TGTSSDVGGYNYVS, DVSNRPS, and SSYTSSSTRV, respectively, (a) a human TGFβRII, or fragment thereof capable of binding TGFβ; and (b) an antibody, or antigen-binding fragment thereof, binding human protein Programmed Death Ligand 1 (PD-L1) comprising (i) a heavy chain variable region including an HVR-H1, an HVR-H2, and an HVR-H3 having the amino acid sequences of SYIMM, SIYPSGGITFYADTVKG and IKLGTVTTVDY, respectively, and (ii) a light chain variable region including an HVR-L1, an HVR-L2, and an HVR-L3, having the amino acid sequences of TGTSSDVGGYNYVS, DVSNRPS, and SSYTSSSTRV, respectively, (i) a heavy chain variable region including an HVR-H1, an HVR-H2, and an HVR-H3 having the amino acid sequences of SYIMM, SIYPSGGITFYADTVKG and IKLGTVTTVDY, respectively, and (ii) a light chain variable region including an HVR-L1, an HVR-L2, and an HVR-L3, having the amino acid sequences of TGTSSDVGGYNYVS, DVSNRPS, and SSYTSSSTRV, respectively, wherein the protein used in combination with radiation of a primary tumor inhibits the growth of a secondary tumor or metastasis distal to the primary tumor treated with radiation.
A process for producing propylene glycol monoalkyl ether comprising: contacting propylene oxide and an alcohol in the presence of an alkali or alkaline earth metal alkoxide catalyst to produce an alkoxylation mixture comprising propylene glycol monoalkyl ether; distilling the alkoxylation mixture at a temperature of from 50 °C to 200 °C and a pressure of from 6.9 KPa to 1034.2 KPa to produce a first overhead stream comprising propylene oxide and the alcohol and a first bottoms stream comprising propylene glycol monoalkyl ether; distilling the first bottoms stream to produce a second overhead stream comprising purified propylene glycol monoalkyl ether and a second bottoms stream comprising heavier byproducts; further distilling the second bottoms stream produce a third overhead stream comprising 2-methoxy-1-propanol and a third bottoms stream comprising dipropylene glycol ether; distilling the third bottoms stream to produce a fourth overhead stream comprising dipropylene glycol ether and the resulting bottoms stream comprising caustic and heavier byproducts; introducing a solid alkali metal borohydride into at least a portion of the resulting bottoms stream to form an alkali metal borohydride containing stream; and introducing the alkali metal borohydride containing stream into one or more distillations upstream of recovery of the second overhead stream. contacting propylene oxide and an alcohol in the presence of an alkali or alkaline earth metal alkoxide catalyst to produce an alkoxylation mixture comprising propylene glycol monoalkyl ether; distilling the alkoxylation mixture at a temperature of from 50 °C to 200 °C and a pressure of from 6.9 KPa to 1034.2 KPa to produce a first overhead stream comprising propylene oxide and the alcohol and a first bottoms stream comprising propylene glycol monoalkyl ether; distilling the first bottoms stream to produce a second overhead stream comprising purified propylene glycol monoalkyl ether and a second bottoms stream comprising heavier byproducts; further distilling the second bottoms stream produce a third overhead stream comprising 2-methoxy-1-propanol and a third bottoms stream comprising dipropylene glycol ether; distilling the third bottoms stream to produce a fourth overhead stream comprising dipropylene glycol ether and the resulting bottoms stream comprising caustic and heavier byproducts; introducing a solid alkali metal borohydride into at least a portion of the resulting bottoms stream to form an alkali metal borohydride containing stream; and introducing the alkali metal borohydride containing stream into one or more distillations upstream of recovery of the second overhead stream.
A haymaking machine , in particular a tedder or windrow spreader with at least one raking rotor comprising a rotor housing having a plurality of tine arms rotating about the rotor axis A and comprising rake tines , characterized by a sensor in the form of a camera which is arranged so that it can detect a pattern, in particular an image pattern (B1, B2) on the ground behind the raking rotor , viewed in the direction of travel, and a controller adjusting the height of the raking rotor as a function of the detected pattern, in particular the image pattern (B1, B2), in particular automatically, wherein the sensor is connected to an evaluation unit able to detect a first image pattern (B1) with arcuate furrows and generates a signal so that the raking rotor can be moved upwards.